0001496298-14-000001.txt : 20140109 0001496298-14-000001.hdr.sgml : 20140109 20140109155558 ACCESSION NUMBER: 0001496298-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140109 DATE AS OF CHANGE: 20140109 EFFECTIVENESS DATE: 20140109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroGenetic Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001496298 IRS NUMBER: 270293096 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-209663 FILM NUMBER: 14518818 BUSINESS ADDRESS: STREET 1: 445 MARINE VIEW AVENUE, SUITE 101 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 858-461-4480 MAIL ADDRESS: STREET 1: 445 MARINE VIEW AVENUE, SUITE 101 CITY: DEL MAR STATE: CA ZIP: 92014 FORMER COMPANY: FORMER CONFORMED NAME: Neurogenetic Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20100712 D 1 primary_doc.xml X0707 D LIVE 0001496298 NeuroGenetic Pharmaceuticals, Inc. 445 MARINE VIEW AVENUE, SUITE 101 DEL MAR CA CALIFORNIA 92014 858-461-4480 DELAWARE Neurogenetic Pharmaceuticals, Inc. Corporation true 2009 William T. Comer 445 Marine View Avenue, Suite 101 Del Mar CA CALIFORNIA 92014 Executive Officer Director Tom Reed 445 Marine View Avenue, Suite 101 Del Mar CA CALIFORNIA 92014 Director Barry Quart 445 Marine View Avenue, Suite 101 Del Mar CA CALIFORNIA 92014 Director Pharmaceuticals Decline to Disclose 06b false 2013-12-31 false true true true false 0 110000 100000 10000 Includes estimated amount receivable by the Issuer upon exercise of a warrant to purchase the Issuer's Preferred Stock; such warrant has not yet been exercised. false 1 0 0 0 false NeuroGenetic Pharmaceuticals, Inc. William T. Comer William T. Comer, Ph.D. President and CEO 2014-01-09